Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications

12 Sept 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Histone Deacetylase Inhibitors Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34510321
DOI: 10.1007/s11033-021-06701-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applicationsPMID 34510321Read ↗

Genetic Alterations of SMYD4 in Solid Tumors Using Integrative Multi-Platform Analysis.Semantic proximity Read ↗

SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus–unrelated nonmultiple head and neck carcinomasSemantic proximity Read ↗

Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic LethalitySemantic proximity Read ↗

Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.Semantic proximity Read ↗

SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent mannerSemantic proximity Read ↗

Expression Profile, Prognostic Value, and Therapeutic Potential of NSD2 in Pan-Cancer: A Systematic Analysis Integrating Multi-Omics DataSemantic proximity Read ↗

Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasisSemantic proximity Read ↗

Emerging roles of DYRK2 in cancerSemantic proximity Read ↗

Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagySemantic proximity Read ↗

Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets.Semantic proximity Read ↗

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic OpportunitiesSemantic proximity Read ↗

Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.